{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:08:15Z","timestamp":1790856495041,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Irish Department of Agriculture Food Institutional Research Measure","award":["11F042"],"award-info":[{"award-number":["11F042"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejpb.2018.04.021","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T12:33:57Z","timestamp":1524227637000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition"],"prefix":"10.1016","volume":"128","author":[{"given":"John P.","family":"Gleeson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas M.","family":"Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin\u00e9ad M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Brayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.04.021_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2018.04.021_b0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nut.2012.12.018","article-title":"Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases\u2013incidence: a systematic review and meta-analysis on observational prospective studies","volume":"29","author":"Salehi-Abargouei","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.ejpb.2018.04.021_b0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/ijms16010256","article-title":"Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension","volume":"16","author":"Majumder","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jcmgh.2016.01.006","article-title":"Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model","volume":"2","author":"Viennois","year":"2016","journal-title":"CMGH Cell. Mol. Gastroenterol. Hepat."},{"key":"10.1016\/j.ejpb.2018.04.021_b0025","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jafc.6b02719","article-title":"Impact of in vitro gastrointestinal digestion and transepithelial transport on antioxidant and ACE-inhibitory activities of Brewers spent yeast autolysate","author":"Vieira","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejpb.2018.04.021_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jprot.2015.01.005","article-title":"Peptide profiling of bovine kefir reveals 236 unique peptides released from caseins during its production by starter culture or kefir grains","volume":"117","author":"Ebner","year":"2015","journal-title":"J. Proteomics"},{"key":"10.1016\/j.ejpb.2018.04.021_b0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tifs.2016.05.007","article-title":"Oral delivery strategies for nutraceuticals: delivery vehicles and absorption enhancers","volume":"53","author":"Gleeson","year":"2016","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.ejpb.2018.04.021_b0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jmr.905","article-title":"Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme","volume":"22","author":"Pina","year":"2009","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.ejpb.2018.04.021_b0045","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1021\/bi049480n","article-title":"Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme","volume":"43","author":"Natesh","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2018.04.021_b0050","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3168\/jds.S0022-0302(95)76745-5","article-title":"Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme","volume":"78","author":"Nakamura","year":"1995","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0055","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2621.2000.tb16049.x","article-title":"Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins","volume":"65","author":"Fujita","year":"2000","journal-title":"J. Food Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0060","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ejcn.2010.3","article-title":"Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects","volume":"64","author":"Jauhiainen","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ejpb.2018.04.021_b0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/08037050902761209","article-title":"Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects","volume":"18","author":"de Leeuw","year":"2009","journal-title":"Blood Press."},{"key":"10.1016\/j.ejpb.2018.04.021_b0070","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jash.2016.03.014","article-title":"Randomized, double-blind, placebo-controlled, cross-over study on the antihypertensive effect of dietary integration with Grana Padano DOCG cheese","volume":"10","author":"Crippa","year":"2016","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.ejpb.2018.04.021_b0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1039\/c2fo10286b","article-title":"A spread containing bioactive milk peptides Ile-Pro-Pro and Val-Pro-Pro, and plant sterols has antihypertensive and cholesterol-lowering effects","volume":"3","author":"Turpeinen","year":"2012","journal-title":"Food. Funct."},{"key":"10.1016\/j.ejpb.2018.04.021_b0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1079\/BJN20051422","article-title":"Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension","volume":"94","author":"Mizuno","year":"2005","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejpb.2018.04.021_b0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/07853890.2012.663926","article-title":"Antihypertensive effects of bioactive tripeptides \u2013 a random effects meta-analysis","volume":"45","author":"Turpeinen","year":"2013","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejpb.2018.04.021_b0090","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejpb.2017.03.007","article-title":"Evaluation of PepT1 transport of food-derived antihypertensive peptides, Ile-Pro-Pro and Leu-Lys-Pro using in vitro, ex vivo and in vivo transport models","volume":"115","author":"Gleeson","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.021_b0095","doi-asserted-by":"crossref","first-page":"e62384","DOI":"10.1371\/journal.pone.0062384","article-title":"VPPIPP and IPPVPP: two hexapeptides innovated to exert antihypertensive activity","volume":"8","author":"Ding","year":"2013","journal-title":"PloS one."},{"key":"10.1016\/j.ejpb.2018.04.021_b0100","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1021\/acs.jafc.5b01824","article-title":"Transport of antihypertensive peptide RVPSL, ovotransferrin 328\u2013332, in human intestinal Caco-2 cell monolayers","volume":"63","author":"Ding","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejpb.2018.04.021_b0105","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1021\/acs.jafc.7b02176","article-title":"Transport study of egg-derived antihypertensive peptides (LKP and IQW) using Caco-2 and HT29 coculture monolayers","volume":"65","author":"Xu","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejpb.2018.04.021_b0110","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1021\/acs.jafc.6b02955","article-title":"Orally available collagen tripeptide: enzymatic stability, intestinal permeability, and absorption of Gly-Pro-Hyp and Pro-Hyp","volume":"64","author":"Sontakke","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejpb.2018.04.021_b0115","first-page":"1753","article-title":"The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation","volume":"2012","author":"Kovacs-Nolan","year":"1820","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2018.04.021_b0120","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/AAC.39.12.2759","article-title":"Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans","volume":"39","author":"Soul-Lawton","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2018.04.021_b0125","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.lfs.2006.08.013","article-title":"Combined administration of captopril with an antihypertensive Val-Tyr di-peptide to spontaneously hypertensive rats attenuates the blood pressure lowering effect","volume":"79","author":"Matsui","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0939-6411(02)00116-9","article-title":"In vitro and in situ evidence for the contribution of Labrasol\u00ae and Gelucire 44\/14 on transport of cephalexin and cefoperazone by rat intestine","volume":"54","author":"Koga","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.021_b0135","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1023\/A:1018823100761","article-title":"Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat","author":"Soderholm","year":"1998","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/nbu.12188","article-title":"Coconut oil \u2013 a nutty idea?","volume":"41","author":"Lockyer","year":"2016","journal-title":"Nutr. Bull."},{"key":"10.1016\/j.ejpb.2018.04.021_b0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.foodcont.2015.08.022","volume":"60","author":"Kim","year":"2016","journal-title":"Food Control."},{"key":"10.1016\/j.ejpb.2018.04.021_b0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.addr.2016.02.004","article-title":"Current status of selected oral peptide technologies in advanced preclinical development and in clinical trails","volume":"106","author":"Aguirre","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.04.021_b0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchromb.2012.08.026","article-title":"Analysis of daidzein in nanoparticles after oral co-administration with sodium caprate to rats by ultra-performance liquid chromatography\u2013quadrupole-time-of-flight mass spectrometry","volume":"907","author":"Ma","year":"2012","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.ejpb.2018.04.021_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2015.05.009","article-title":"Stability, toxicity and intestinal permeation enhancement of two food-derived antihypertensive tripeptides, Ile-Pro-Pro and Leu-Lys-Pro","volume":"71","author":"Gleeson","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2018.04.021_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1567201052772834","article-title":"Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery","volume":"2","author":"Cano-Cebrian","year":"2005","journal-title":"Curr. Drug Del."},{"key":"10.1016\/j.ejpb.2018.04.021_b0170","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ejpb.2014.10.008","article-title":"A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells","volume":"88","author":"Brayden","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.04.021_b0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biomaterials.2012.09.051","article-title":"C. I., M. Fromm, S. Amasheh, Sodium caprate as an enhancer of macromolecule permeation across tricullular tight junctions of intestinal cells","volume":"34","author":"Krug","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.04.021_b0180","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11095-007-9527-6","article-title":"Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro","volume":"25","author":"Feighery","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.021_b0185","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2018.04.021_b0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2005.02.009","article-title":"pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers","volume":"25","author":"Neuhoff","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0195","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejps.2012.08.010","article-title":"Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers","volume":"47","author":"Petersen","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2016.03.063","article-title":"Excised segments of rat small intestine in Ussing chamber studies: a comparison of native and stripped tissue viability and permeability to drugs","volume":"505","author":"Sjogren","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.021_b0205","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/bph.12856","article-title":"Experimental design and analysis and their reporting: new guidance for publication in BJP","volume":"172","author":"Curtis","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.04.021_b0210","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1124\/dmd.112.044990","article-title":"Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studies","volume":"40","author":"Poirier","year":"2012","journal-title":"Drug Metab. Disposition"},{"key":"10.1016\/j.ejpb.2018.04.021_b0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-5173(03)00407-1","article-title":"Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats","volume":"265","author":"Sasaki","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.021_b0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejps.2008.08.004","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"Hayeshi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(02)00047-7","article-title":"Synthesis of analogs of l-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells","volume":"16","author":"Friedrichsen","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0230","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.peptides.2007.11.006","article-title":"Identification of ACE-inhibitory peptides in salt-free soy sauce that are transportable across caco-2 cell monolayers","volume":"29","author":"Zhu","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2018.04.021_b0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2012.10.007","article-title":"Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique","volume":"48","author":"Sj\u00f6berg","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0240","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.peptides.2008.03.021","article-title":"The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models","volume":"29","author":"Foltz","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2018.04.021_b0245","first-page":"364","article-title":"Hijacking solute carriers for proton-coupled drug transport","volume":"25","author":"Anderson","year":"2010","journal-title":"Physiology (Bethesda, Md.)"},{"key":"10.1016\/j.ejpb.2018.04.021_b0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00580717","article-title":"pH-microclimate at the luminal surface of the intestinal mucosa of guinea pig and rat","volume":"407","author":"Rechkemmer","year":"1986","journal-title":"Pfl\u00fcgers Archiv."},{"key":"10.1016\/j.ejpb.2018.04.021_b0255","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s11095-014-1350-2","article-title":"Laurate permeates the paracellular pathway for small molecules in the intestinal epithelial cell model HT-29\/B6 via opening the tight junctions by reversible relocation of claudin-5","volume":"31","author":"Dittmann","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.021_b0260","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s11095-014-1303-9","article-title":"A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms","volume":"31","author":"Tuvia","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.021_b0265","doi-asserted-by":"crossref","first-page":"e1176822","DOI":"10.1080\/21688370.2016.1176822","article-title":"Safety concerns over the use of intestinal permeation enhancers: a mini-review","volume":"4","author":"McCartney","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ejpb.2018.04.021_b0270","first-page":"G967","article-title":"PG-mediated closure of paracellular pathway and not restitution is the primary determinant of barrier recovery in acutely injured porcine ileum","volume":"285","author":"Gookin","year":"2003","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejpb.2018.04.021_b0275","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","article-title":"Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.021_b0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4155\/tde.10.5","article-title":"Restoration of rat colonic epithelium after in situ intestinal instillations of the absorption promoter, sodium caprate","volume":"1","author":"Wang","year":"2010","journal-title":"Therapeutic Del."},{"key":"10.1016\/j.ejpb.2018.04.021_b0285","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1208\/s12249-009-9345-8","article-title":"Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design","volume":"10","author":"Bejugam","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.04.021_b0290","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1002\/jps.22627","article-title":"Effect of milk on the pharmacokinetics of oseltamivir in healthy volunteers","volume":"100","author":"Morimoto","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0295","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11095-011-0580-9","article-title":"Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice","volume":"29","author":"Ma","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.021_b0300","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/jpet.108.143339","article-title":"Transport of angiotensin-converting enzyme inhibitors by H+\/peptide transporters revisited","volume":"327","author":"Kn\u00fctter","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2018.04.021_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cofs.2014.12.008","article-title":"Enhancing nutraceutical bioavailability through food matrix design","volume":"4","author":"McClements","year":"2015","journal-title":"Curr. Opin. Food Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0310","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jff.2013.12.010","article-title":"Common delivery systems for enhancing in vivo bioavailability and biological efficacy of nutraceuticals","volume":"7","author":"Ting","year":"2014","journal-title":"J. Funct. Food"},{"key":"10.1016\/j.ejpb.2018.04.021_b0315","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/ijms17121977","article-title":"Enhanced and extended anti-hypertensive effect of VP5 nanoparticles","volume":"17","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2018.04.021_b0320","first-page":"1","volume":"10","author":"EFSA","year":"2012","journal-title":"EFSA J."},{"key":"10.1016\/j.ejpb.2018.04.021_b0325","first-page":"1","article-title":"Panel on Dietetic Products, Nutrition and Allergies, Scientific Opinion on the substantiation of health claims related to bonito protein peptide and maintenance of normal blood pressure (ID 1716) pursuant to Article 13(1) of Regulation (EC) No 1924\/2006","volume":"8","author":"EFSA","year":"2010","journal-title":"EFSA J."},{"key":"10.1016\/j.ejpb.2018.04.021_b0330","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ajh\/hps044","article-title":"Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials","volume":"26","author":"Cicero","year":"2013","journal-title":"Am. J. Hyperten."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117308986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117308986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:31:01Z","timestamp":1760545861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117308986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":66,"alternative-id":["S0939641117308986"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.021","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}